Deal Snapshot
LUMINEX TO ACQUIRE FLOW CYTOMETRY PORTFOLIO OF MILLPORESIGMA FOR USD 75M
Monday 22 October 2018

Texas, US-based Luminex Corp. (NASDAQ: LMNX) has agreed to acquire the flow cytometry portfolio of Massachusetts, US-based chemical and biochemical product‎s provider MilliporeSigma's flow cytometry portfolio for USD 75m, the company said.
The transaction consists of approximately USD 69.9m to be paid under a stock and asset purchase agreement and approximately USD 5.1m in committed inventory purchases. The deal is expected to close by the end of 2018, and to contribute USD 40m to USD 50m in revenue to the company in 2019.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 22/10/2018
Target: MilliporeSigma/flow cytometry portfolio
Country: USA
Deal Size: 75m (USD)
Sector: Machinery/Engineering
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor: MilliporeSigma
Buyer: Luminex Corp
Buyer Advisor: Cantor Fitzgerald and Co , Smith, Gambrell and Russell
Comment:


Options